This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by DLA Piper and The Lawyer. The report discusses the current developments and key global issues in this field from the perspective of M&A/corporate, litigation, data protection, IPT and life sciences regulatory, among others.
| less than a minute read
Digital Therapeutics - evolution and entry into mainstream healthcare
Despite all regulatory challenges, the critical role of physicians in determining the success of digital therapeutics cannot be stressed enough.
This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...